Reville PK, Sasaki K, Kantarjian HM, Daver NG, et al. Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. Am J Hematol 2022 Jan 3. doi: 10.1002/ajh.26451.
PMID: 34981570